Donating Oral Mucosal Cells for the Study of ex Vivo Culture of Cells Sheets
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Cultivated oral mucosal epithelial sheets on amniotic membrane have been reported to have good clinical results in treating patients with ocular surface disorders in both human and animal studies. However, such technique has not been well established in this hospital. The main purpose of this study is to obtain the discarded oral mucosal tissue from healthy donors who volunteer to donate their oral mucosa from buccal area. The obtained oral mucosal tissue will be cultured under different types (co-culture with or without 3T3 cells)。Inverted light microscopy, electron microscopy and immunostaining with K3/K12, K14, Ki67, P63, connexin 43, and involucrin will be preformed to test the effects of foreskin cell line co-culture system on cell condition. The investigators plan to start the study from Jan. 1st, 2011 to Dec. 31th, 2015. Thirty patients will be enrolled.
| Condition | Intervention |
|---|---|
|
Healthy |
Procedure: Donating oral mucosal cells |
| Study Type: | Observational |
| Study Design: | Observational Model: Case-Only |
Donating oral mucosal cells for the study of ex vivo culture of cells sheets.
| Estimated Enrollment: | 1 |
| Study Start Date: | January 2012 |
| Estimated Study Completion Date: | December 2015 |
| Estimated Primary Completion Date: | December 2015 (Final data collection date for primary outcome measure) |
| Groups/Cohorts | Assigned Interventions |
|---|---|
| Health people. |
Procedure: Donating oral mucosal cells
Donating oral mucosal cells
|
Eligibility| Ages Eligible for Study: | 20 Years to 55 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Non-Probability Sample |
Health people.
Inclusion Criteria:
- The age 20 to 55 year-old healthy contributor.
- does not have disease of the oral cavity.
Exclusion Criteria:
- In the past had the oral mucosa disease, wound cicatrization bad, or hemoglutination condition not good medical history. Sickness must stop using above any anti-hemoglutination medicine one week.
Contacts and Locations| Contact: Wei Li Chen, MD, PhD | 886-2-23123456 ext 65206 | chenweili@ntu.edu.tw |
| Taiwan | |
| National Taiwan University Hospital, department of Ophthalmology | Recruiting |
| Taipei, Taiwan, 100 | |
| Contact: Wei Li Chen, MD, PhD 886-2-23123456 ext 65206 chenweili@ntu.edu.tw | |
More Information
No publications provided
| Responsible Party: | National Taiwan University Hospital, Wei-Li Chen/Assistant Professor, National Taiwan University, Department of Ophthalmology. |
| ClinicalTrials.gov Identifier: | NCT01548261 History of Changes |
| Other Study ID Numbers: | 201110051RB |
| Study First Received: | March 5, 2012 |
| Last Updated: | March 7, 2012 |
| Health Authority: | Taiwan: Department of Health |
Keywords provided by National Taiwan University Hospital:
|
obtain the oral mucosal tissue from healthy donors |
ClinicalTrials.gov processed this record on May 21, 2013